CTIC 0.91 -0.01 / CELL THERAPEUTICS News | Benzinga

Thursday, May 10, 2012

Cell Therapeutics' Pixuvri Approved in European Union as Monotherapy to Treat Adult Patients with Multiply Relapsed or Refractory Aggressive Non-Hodgkin B-Cell Lymphomas (CTIC, News, FDA / Thu, 02:31pm)

Friday, April 20, 2012

Earnings Scheduled For April 20 (AEP, AOS, BPOP, CTIC, Earnings, GE, HON, IDXX, IR, JCI, KMB, MAN, MCD, News, ORB, RCL, SLB, SXT, UA, Pre-Market Outlook, Markets / Fri, 04:29am)

Thursday, April 19, 2012

Benzinga's M&A Chatter for Thursday April 19, 2012 (APO, CTIC, GSK, HGSI, Long Ideas, News, WOLF, Short Ideas, Rumors, M&A, After-Hours Center, Movers, Trading Ideas / Thu, 06:03pm)
From Earlier: Cell Therapeutics Enters into Agreement to Acquire Pacritinib, a Novel Highly Selective JAK2 Inhibitor Phase 3 Candidate for Myelofibrosis (CTIC, News, M&A / Thu, 07:49am)

Friday, February 17, 2012

European Medicines Agency's Committee For Medicinal Products For Human Use Issues Positive Opinion For Conditional Approval On Marketing Authorization Application For Pixuvri™ (CTIC, News, FDA / Fri, 08:36am)

Monday, January 30, 2012

Morning Market Losers (CTIC, MNEL, News, RGDX, Movers & Shakers, Intraday Update, Markets / Mon, 11:08am)
Cell Therapeutics Plummeting on NDA Withdrawl (CTIC, News, FDA, Intraday Update, Movers / Mon, 10:52am)
From Earlier: Cell Therapeutics Withdraws New Drug Application for Pixuvri and Plans to Resubmit in 2012 (CTIC, News, FDA / Mon, 07:46am)

Tuesday, January 03, 2012

From Earlier: Cell Therapeutic Announces FDA's Oncologic Drugs Advisory Committee to Review Resubmitted Pixantrone New Drug Application on February 9, 2012 (CTIC, News, FDA / Tue, 08:16am)

Monday, December 19, 2011

A Peek Into The Market Before The Trading Starts (CTIC, GLPYY, GSK, KTOS, LAZ, News, RPTP, Futures, Global, Pre-Market Outlook, Markets / Mon, 08:30am)
Cell Therapeutics Retires Remaining Convertible Debt (CTIC, News, Financing / Mon, 07:54am)

Tuesday, December 13, 2011

Final OPAL Phase II Results of Tosedostat Demonstrate Significant Response Rates in Elderly Patients with Treatment Refractory or Relapsed Primary or Secondary Acute Myeloid Leukemia (CTIC, News, FDA / Tue, 08:26am)

Monday, December 12, 2011

Stocks To Watch For December 12 (ABB, BCSI, COO, CTIC, Earnings, News, M&A, Pre-Market Outlook, Markets, Trading Ideas / Mon, 04:28am)

Friday, December 09, 2011

Cell Therapeutics Announces Institutional Investors Purchase $20M of Preferred Stock and Warrants (CTIC, News, Offerings / Fri, 08:24am)

Friday, December 02, 2011

Cell Therapeutics Board Awards CEO $150K Bonus for 20 Year Service; Company down Over 99% in 5 Year Timeframe (CTIC, News, Management, Media / Fri, 10:21am)

Monday, November 21, 2011

U.S. Patent Office Issues Notice of Allowance for Patent Application Related to CTI's GlycoPolymer Technology (CTIC, News / Mon, 08:34am)

Tuesday, October 25, 2011

Celgene Earnings Preview: Analysts Expect Higher EPS, Revenue (BMY, CELG, CTIC, Earnings, GSK, Long Ideas, News, Short Ideas, Previews, Trading Ideas / Tue, 12:10pm)
Cell Therapeutics Resubmits Pixantrone NDA to FDA for Consideration of Accelerated Approval (CTIC, News, FDA / Tue, 06:27am)

Wednesday, August 31, 2011

Morning Market Movers (ADES, CTIC, DMED, ENOC, News, Intraday Update, Markets, Movers / Wed, 09:50am)

Tuesday, August 23, 2011

Cell Therapeutics Submits Day 120 Response for Pixantrone Marketing Authorization Application to European Medicines Agency (CTIC, News, FDA / Tue, 06:49am)

Thursday, August 18, 2011

Randomized Study Comparing Cell Therapeutics' OPAXIO and Radiotherapy to Standard of Care Temozolomide and Radiotherapy Treatment Open for Enrollment (CTIC, News, FDA / Thu, 06:51am)

Monday, July 25, 2011

Celgene Earnings Preview: Analysts Expect Falling Revenue, Rising EPS Over Last Quarter (BMY, CELG, CTIC, Earnings, GSK, Long Ideas, News, Short Ideas, Previews, Trading Ideas / Mon, 02:20pm)

Thursday, June 30, 2011

Morning Market Losers (CTIC, DL, News, SCMF, SYNM, Movers & Shakers, Intraday Update, Markets / Thu, 09:58am)

Friday, June 17, 2011

Pixantrone in Combination with Others Produces High Rates of Complete Remissions in Patients with Relapsed or Refractory Indolent Non-Hodgkins Lymphoma (CTIC, News, FDA / Fri, 08:06am)

Tuesday, June 14, 2011

Cell Therapeutics Completes Type A Meeting With FDA's Division of Oncology Drug Products: Guidance Provided for Resubmission of Pixantrone NDA for Consideration of Accelerated Approval (CTIC, News, FDA / Tue, 06:56am)

Friday, March 11, 2011

Cell Therapeutics Rises 40% (CTIC) (CTIC, News, FDA, Intraday Update, Movers / Fri, 05:31pm)

Wednesday, February 16, 2011

Cell Therapeutics Reports Q4 Loss of $0.04 per share (CTIC, Earnings, News / Wed, 06:58am)

Wednesday, October 20, 2010

Adam Feuerstein Thinks Merger May Be In Works In Biotech (CTIC, SNSS) (CTIC, News, SNSS, Rumors, M&A / Wed, 11:40am)

Thursday, June 03, 2010

Axia Slashes Estimates for Cell Therapeutics (CTIC) (Analyst Color, CTIC, News, FDA, Intraday Update, Analyst Ratings / Thu, 03:20pm)

Monday, May 24, 2010

Cell Therapeutics (CTIC) Plunges On Double Whammy (CTIC, News, Short Ideas, Small Cap Analysis, Technicals, Movers, Trading Ideas / Mon, 12:48pm)

Monday, March 08, 2010

Movers And Shakers For March 8, 2010 (CTIC, HLX, IMAX, Long Ideas, News, RIMM, S, XRTX, Intraday Update, Markets, Movers, Trading Ideas / Mon, 03:57pm)

Thursday, March 04, 2010

Cell Therapeutics Higher After Review Rescheduled (CTIC) (CTIC, News, FDA, Markets, Movers / Thu, 03:38pm)

Friday, February 19, 2010

Taking Long Position In Cell Therapeutics Leap Call Options (CTIC) (CTIC, Long Ideas, News, Options, Rumors, Small Cap Analysis, Markets, Trading Ideas / Fri, 03:48pm)

Wednesday, January 13, 2010

Cell Therapeutics Dilutes Shareholders...Again! (CTIC) (CTIC, News, Offerings, Intraday Update / Wed, 09:20pm)

Friday, November 20, 2009

Cell Therapeutics (CTIC) Wins Federal Appeal to Pursue $22.8M Claim Against The Lash Group (CTIC, News / Fri, 06:52am)

Monday, November 02, 2009

Cell Therapeutics, Inc. (CTIC) to Announce Q3 Report Financial Results on November 5 (CTIC, Earnings, News / Mon, 05:34am)